Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike van Verseveld

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 11, 2023
[IV esketamine for patients with a treatment-resistant depression]Sven Stuiver, Mike Van Verseveld, Mark V Koning, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 26, 2023
[Consider (es)ketamine for treatment-resistant depression]Mike van Verseveld, Sven Stuiver, Cornelis F Vos, et al.
BJGP Open|May 8, 2026
Exploring psychotropic medication use in Dutch primary care: trends, prevalence, and associations with polypsychopharmacyJulia Cybulska, Mike Van Verseveld, Arnt Fa Schellekens, et al.
AIDS and Behavior|April 27, 2021
Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIVLisa Van de Wijer, Wouter van der Heijden, Mike van Verseveld, et al.
Psychological Medicine|July 24, 2023
Development and validation of a multimodal neuroimaging biomarker for electroconvulsive therapy outcome in depression: a multicenter machine learning analysisWillem Benjamin Bruin, Leif Oltedal, Hauke Bartsch, et al.
Brain Stimulation|July 30, 2023
Effective resting-state connectivity in severe unipolar depression before and after electroconvulsive therapyFreek Ten Doesschate, Willem Bruin, Peter Zeidman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|August 11, 2023
[IV esketamine for patients with a treatment-resistant depression]Sven Stuiver, Mike Van Verseveld, Mark V Koning, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 26, 2023
[Consider (es)ketamine for treatment-resistant depression]Mike van Verseveld, Sven Stuiver, Cornelis F Vos, et al.
BJGP Open|May 8, 2026
Exploring psychotropic medication use in Dutch primary care: trends, prevalence, and associations with polypsychopharmacyJulia Cybulska, Mike Van Verseveld, Arnt Fa Schellekens, et al.
AIDS and Behavior|April 27, 2021
Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIVLisa Van de Wijer, Wouter van der Heijden, Mike van Verseveld, et al.
Psychological Medicine|July 24, 2023
Development and validation of a multimodal neuroimaging biomarker for electroconvulsive therapy outcome in depression: a multicenter machine learning analysisWillem Benjamin Bruin, Leif Oltedal, Hauke Bartsch, et al.
Brain Stimulation|July 30, 2023
Effective resting-state connectivity in severe unipolar depression before and after electroconvulsive therapyFreek Ten Doesschate, Willem Bruin, Peter Zeidman, et al.
Pageof 1